New human stem cell platform will expand access to standardized disease models, support Parkinson's disease research and therapeutic discovery efforts NEW YORK , June 9,...
Luxury Open-View Fireplaces Deliver Tall Flames, Whisper-Quiet Performance, and Limitless Design PossibilitiesBIG LAKE, Minn., June 9, 2026 /PRNewswire/ -- Acucraft, a leading manufacturer of...
L'ABCD Edutainment Leverages zSpace Immersive Platform to Transform 2D Ultrasound Images into Interactive 3D Anatomical Models, Advancing Medical Imaging and AI-Based Diagnostics
L'ABCD Edutainment Leverages zSpace Immersive Platform to Transform 2D Ultrasound Images into Interactive 3D Anatomical Models, Advancing Medical Imaging and AI-Based Diagnostics
- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma
- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers
DELRAY BEACH, Fla., June 9, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the EV Battery Market is projected to reach USD 168.95 billion by 2035, from USD...
AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity
SINGAPORE, June 9, 2026 /PRNewswire/ -- Today, OpenWay, a global provider of digital payment software, announces its collaboration with Visa, a global leader in digital...
GUANGZHOU, China, June 09, 2026 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading advanced air mobility (“AAM”) technology platform company, today announced its unaudited financial results for the first quarter ended March 31, 2026.
BASEL, Switzerland, June 09, 2026 (GLOBE NEWSWIRE) -- FloBiotech today announced an agreement with UCLA Health to advance a novel class of therapeutics targeting biologically validated protective pathways in neurodegeneration.
Grant awarded through the Parkinson's Disease Therapeutics Pipeline Program tosupport advancement of Harness' new programme targeting GCase and LIMP2 for Parkinson's disease
SHENZHEN, China, June 9, 2026 /PRNewswire/ -- Under the theme "Together, Advancing Inclusive & Intelligent Education and Healthcare," Huawei successfully hosted the Huawei APAC...
SYDNEY, June 8, 2026 /PRNewswire/ -- UQPAY (AU) has integrated with Circle Payments Network (CPN), a coordination layer operated by Circle Technology Services, LLC,...